Searched for
ZYDUS SHARE SALE
Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...- Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the J...
- Ahead of Market: 10 things that will decide stock market action on FridayBSE Sensex and Nifty 50 extended gains for a second session, led by banking, metal and pharma stocks despite IT weakness. Analysts flagged ...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Zydus Lifesciences to raise Rs 5,000 cr via equity; Q2 profit up 38%Zydus Lifesciences plans to raise Rs 5,000 crore via share sales. This move aims to reduce debt and boost future expansion. Funds will supp...
- Zydus Lifesciences shares in focus after USFDA nod for Celecoxib capsulesZydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will manufacture the drug...
- Zydus gets USFDA nod for generic drug to treat multiple sclerosisZydus Lifesciences has secured USFDA approval to market Glatiramer Acetate Injection, a generic version of Copaxone, for treating relapsing...
- Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...
- Zydus Lifesciences Q3 Results: Firm beats profit estimates; approves shares buybackIndian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit on Friday, driven by strong sales ...
- Zydus Lifesciences Q1 Results: Profit more than doubles on US sales growthIts U.S formulations business saw a revenue growth of 57.4% to 24.54 billion rupees, while India formulations grew by 9.1% to 12.27 billion...
- Zydus Wellness Q4 results: Net profit surges 92.6% to Rs 133.13 croreFor the fiscal year ended March this year, the company posted a net profit of Rs 118.73 crore as against Rs 141.72 crore for the previous f...
- Zydus & CMS enter pact for Desidustat in Greater ChinaThe agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease (CKD) no...
- Zydus Cadila acquires six brands from Merck IndiaThe acquired brands Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range had clocked sales of Rs 840 million in 2015.
- Zydus Wellness posts Q3 net profit at Rs 27.25 croreZydus Wellness reported a consolidated net profit of Rs 27.25 crore for the third quarter ended December 31, 2015.
- Heard on the Street: JV with NSDC boosts Everonn EducationShares of Everonn Education ended firm in a falling market on Monday, after the company signed a JV agreement with India’s National Skill D...
- Zydus, Teva end patent disputesAhmedabad-based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients (APIs)...
- Zydus Cadila surges on drug discovery pact with Eli LillyShares of Zydus Cadila got a booster shot after the pharmaceutical company signed a new drug discovery and development agreement with Eli L...
Load More
